1-Phenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 95.0%, 10g

4-Amino-3,5-difluorobenzonitrile, 95.0%, 1g

1,3-Dibromo-2-fluoro-4-nitrobenzene, 95.0%, 100mg

ethyl 2-[(chloroacetyl)amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate, 95.0%, 1g

DL-cistina, mínimo 98,5 %, 1 g, envase de vidrio

3-Vinyl-1,1'-biphenyl, 97%, 250mg

4-(chloromethyl)-2-(3-methylphenyl)-1,3-thiazole, 95.0%, 1g

tert-Butyl 3-oxo-2,8-diazaspiro[4.5]decane-8-carboxylate, 95.0%, 10g

1-(diazyn-1-ium-1-yl)-12-hydroxy-4,7,10-trioxa-1-azadodecan-1-ide, >97.0%(GC), 1g

4-(Trifluoromethyl)nicotinic acid, 98.0%, 1g

6-Bromo-4-fluoro-2-methyl-2h-indazole, 98%, 1g

3,5-Dichlorobenzenesulfonamide, 97.0%, 100g

4-(4-Nitrophenyl)morpholine>98.0%(GC)(T)5g